Back

Personalized rate control treatment for atrial fibrillation: a prospective case-control study on the use of diltiazem

16 April 2023 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: ePoster session 19 Rate Control EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Alberto Spadotto

Alma Mater Studiorum, University of Bologna, Bologna (Italy)

9 More presentations in this session

Presentation thumbnail
Left atrial Strain as a predictor of atrial fibrillation recurrence after catheter ablation
Doctor D. Blyalova (Astana, KZ)
Abstract Slides
Presentation thumbnail
New onset, recurrence and progression of atrial fibrillation after cardiac surgery during 2.5 years of continuous rhythm monitoring
Mr M. Kawczynski (Maastricht, NL)
Abstract Slides
Presentation thumbnail
High efficacy single catheter standardized workflow for radiofrequency ablation of atrial fibrillation in the high-power short-duration era
Doctor C. Valeriano (Rozzano, IT)
Abstract Slides
Presentation thumbnail
Catheter ablation as first-line treatment in patients with atrial fibrillation: a Bayesian network meta-analysis
Doctor C. BONANNO (Vicenza, IT)
Abstract Slides
Presentation thumbnail
Opposite evolution on voltage and thickness from paroxysmal to persistent AF
Mr E. Silva Garcia (Sevilla, ES)
Abstract Slides

Access the full session

Session thumbnail
ePoster session 19

The Event

Event poster

EHRA 2023

16 April - 18 April 2023
You may be interested in
thumbnail
Congress Presentation
A call for timely rhythm control strategy
thumbnail
Webinar
Making better decisions on rhythm control for AF to improve patient symptoms and morbidity
thumbnail
Congress Presentation
Medical treatment of atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources